Chemotherapy of Pancreatic, Colorectal and Gastric Cancer

摘要: Pancreatic cancer currently represents the fifth leading cause of death in this country; its toll is surpassed only by lung, colon and rectum, breast, prostate [1]. The therapeutic modality with potential for cure surgery, even surgery rate exceedingly low. Most patients present localized or regional disease but an attempt at resection warranted a minor fraction because involvement major abdominal structures [2]. Gudjonsson et al. [3] have analyzed 100 from their own institution reviewed number series literature. They calculate median survival 5 1/2 months time first symptoms, four histologically confirmed diagnosis, one year 10% five 1% (a single patient who survived eight years palliative bypass procedure without resection). estimate review literature that 80% carcinoma pancreas come to exploration; however, 10–15% these are resected cure. Fewer than survive years, many institutions failed record survival.